Please login to the form below
trial transparency
This page shows the latest trial transparency news and features for those working in and with pharma, biotech and healthcare.
EMA to support real-world monitoring of COVID-19 treatments/vaccines
The agency called for transparency surrounding trial protocols and results, and collaboration between researchers to ensure high-quality studies.
Latest news
-
UCB launches online clinical trial tool
Although UCB signed up to a clinical trial data sharing portal in 2014 it only received a mid-table ranking from an AllTrials audit last year. ... Industry-wide pressure from the campaigning group is set to be increased following the drive to name trial
-
AllTrials tracker site names clinical trial non-reporters
fine trial sponsors up to $10, 000 per day who fail to publish results “there are, though, trials on that register whose results are years overdue, and to date you have
-
Shire says all its studies will publish in open access journals
The new policy comes against a backdrop of a lot of promises by the pharma industry to improve on transparency that have often fallen short. ... Last year for example, an audit of 42 top manufacturers from the EU, US and Japan by the trial transparency
-
The state of trust
The campaign group has been at the forefront of efforts to increase clinical trial transparency - through open publication - and a year ago revealed that around half of all trials run by ... We have been in conversation with AllTrials to make sure that
-
Audit exposes gaps in pharma's promises on trial transparency
study. An audit of 42 top manufacturers from the EU, US and Japan by the trial transparency pressure group AllTrials reveals that GlaxoSmithKline sits at the top of the tree for ... transparency, followed by LEO Pharma, Takeda, Pfizer, Novartis, Novo
More from news
Approximately 3 fully matching, plus 74 partially matching documents found.
Latest Intelligence
-
LEO: Patients benefit from transparency
LEO’s VP for Europe North Geraldine Murphy (pictured above) sat down with PME to talk about trial transparency and why opening up is so important. ... Every company has their own policies regarding trial transparency, but we need to begin to learn to
-
Interview: Beate Wieseler, IQWIG
That is still open.”. IQWiG and clinical trial transparency. In addition to its role in German drug pricing, IQWiG has also emerged as one of the leading organisations in the campaign ... for greater transparency of clinical trial detail, becoming one
-
VIDEO interview: Neil Weir, UCB
Issue of transparency. It's a similar story when it comes to pharma's hot topic of the past 12 months – transparency of clinical trial data. ... on transparency as part of his role on EFPIA's research directors group.
-
Clinical trial regulation in Mexico
private hospital and trial centres can be found concentrated in large urban areas. ... Moreover, training for clinical trial personnel, eg managers and coordinators, is also improving.
More from intelligence
Approximately 1 fully matching, plus 3 partially matching documents found.
Latest appointments
-
Sanofi CEO Viehbacher to head EFPIA
One of the most pressing matters for EFPIA is the seemingly inevitable trend towards transparency of trial data, and Viehbacher has already commented on the subject.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
How to measure and maximise your patient recruitment spend ROI
Using emotion to connect with people through your clinical trial advertising is important. ... Customised, adaptable digital marketing campaigns, better sharing and transparency of data, health seeker-centric trial design, and remote patient monitoring
-
New ICMJE Guidelines and their Impact on Biotech
Failure to do so will prevent the reporting of trial results in an ICMJE member journal, and probably many other journals that adhere to ICMJE guidelines. ... While the goal of ICMJE of increasing transparency in the reporting of clinical trial data is
-
Clinical data Transparency
As the date for legislation approaches, each week brings more debate regarding the issue of clinical data transparency. ... Within the industry there appears to an appetite for increased transparency, with recognition of the scientific and patient
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
Subscribe to our email news alerts
- Medscape Education’s Large Presence at IDWeek 2023
- WHO recommends second malaria vaccine for children
- Sanofi enters agreement with Janssen to develop E. coli vaccine candidate
- NFID and CDC urge US adults to get vaccinated against flu and COVID-19
- Man vs microbe: the fight against antimicrobial resistance
- Dollo's law
No results were found
PMHub
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...
Latest intelligence
- Man vs microbe: the fight against antimicrobial resistance
- How the emerging resistance to antibiotics is being exacerbated by a lack of research and development into new antibiotics...
- Is trust the key factor in digital HCP engagement? New whitepaper from Graphite Digital
- Based on research with HCPs in the UK, USA and France, Graphite Digital’s latest whitepaper sheds light on HCP perceptions of pharma-owned digital channels, and what organisations should be prioritising...
- HOW TO TRANSFORM YOUR HEALTHCARE BRAND MARKETING FROM MULTI-CHANNEL TO OMNICHANNEL
- In a previous blog, we outlined the role of omnichannel in healthcare and the importance of personalised communications with the suggestion of using modular content to support an omnichannel approach....
